Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,058 | Dovepress* | 6,058+ | 2,334 | 8,392 | |
Totals | 6,058 | 2,334 | 8,392 | ||
*Since 8 August 2008 +Since July 2016 |
View citations on Google Scholar